Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sargramostim Phase 1/2 Study in Active Crohn's Disease
NCT00329537Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Jun 2006
- Primary completion
- May 2007
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of sargramostim in Crohn's disease, sponsored by Sanofi. Started Jun 2006; status: terminated.
02
Drugs
sargramostim
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00329537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329537.